ClinicalTrials.Veeva

Menu

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis

I

Institutul Clinic Fundeni

Status

Completed

Conditions

Sepsis

Treatments

Procedure: CytoSorb

Study type

Observational

Funder types

Other

Identifiers

NCT04533256
Cyto-Sepsis

Details and patient eligibility

About

Hemoadsorption has been demonstrated to improve clinical and paraclinical results in critically ill patients with sepsis and septic shock. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with sepsis, on organ failure, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with sepsis or septic shock who require hemoadsorption in accordance with local guidelines

Exclusion criteria

  • unsigned informed consent
  • duration of therapy under 12 hours
  • death before the three consecutive sessions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems